Status:
COMPLETED
CM Delivered PST in LLD Pilot
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
Bell Let's Talk Community Fund
Conditions:
Late Life Depression
Eligibility:
All Genders
60+ years
Phase:
PHASE1
Brief Summary
This study seeks to determine the feasibility and efficacy of a Problem Solving Therapy intervention for the treatment of late life depression (LLD). Participants diagnosed with LLD will participate i...
Detailed Description
The study will be a single-centre, open-label, longitudinal, pragmatic, pilot trial. Research participants at this site will be 40 men and women between the ages of 60 and 85 who have mild to moderate...
Eligibility Criteria
Inclusion
- Participants will be considered eligible for the study if they:
- Are of either gender and 60 years of age or greater.
- Reside in a community setting (either independent living environment or retirement home).
- Meet diagnostic criteria for major depressive disorder (MDD) according to the Diagnostic and Statistical Manual of Mental Disorders-V (DSM-V) criteria.
- Have a Hamilton Depression Rating Scale (HAMD) 17-item total score of \>= 8 and \< 24 at baseline.
- Have a Mini Mental Status Exam score of \>= 25.
- Have adequate hearing and vision to be able to participate in Problem Solving Therapy, with no significant sensory impairment
- Fluent in English both written and oral.
Exclusion
- Participants will be considered ineligible for participating in the study if they:
- Have suicidal ideation requiring inpatient admission to hospital for stabilization.
- Have an unstable medical condition requiring hospital admission.
- Have a life expectancy of less than 6 months or are currently receiving palliative care.
- Have psychotic symptoms.
- Have a lifetime history of bipolar disorder or schizophrenia.
- Are currently alcohol dependent or have another substance dependence.
- Are diagnosed with moderate to severe dementia.
- Are planning admission to a long-term care facility within next 6 months.
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2019
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT03408821
Start Date
February 1 2018
End Date
May 31 2019
Last Update
June 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sciences Centre
London, Ontario, Canada, N6A 5W9